This inventor holds 4 USPTO granted patents and 4 EPO patents. Top assignees: Biochemistry of the Academy of Sciences of the Czech Republic, Institute of Organic Chemistry, Institute of Organic Chemistry and Biochemistry. Active years: 1999-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2006
Title: The Innovative Contributions of Antonin Holy
Introduction
Antonin Holy is a notable inventor based in Horni Pocernice, Czech Republic. He has made significant contributions to the field of organic chemistry, particularly in the development of antiviral compounds. With a total of four patents to his name, Holy's work has implications for therapeutic methods and drug synthesis.
Latest Patents
Among his latest patents, Holy has developed phosphonate substituted pyrimidine compounds and methods for therapy. These novel compounds are characterized by a specific formula where various components are defined. Additionally, he has provided antiviral methods for use and processes for synthesizing these compounds. His work in antiviral compounds and methods for synthesis and therapy showcases his innovative approach to addressing health challenges.
Career Highlights
Throughout his career, Antonin Holy has been associated with the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. His research has focused on creating effective antiviral agents, contributing to advancements in medical science. His dedication to innovation in chemistry has positioned him as a key figure in his field.
Collaborations
Antonin Holy has collaborated with esteemed colleagues such as Jan M R Balzarini and Erik D A De Clercq. These partnerships have enhanced his research efforts and expanded the impact of his inventions.
Conclusion
Antonin Holy's contributions to the field of organic chemistry and his innovative patents reflect his commitment to advancing therapeutic methods. His work continues to influence the development of antiviral treatments, showcasing the importance of innovation in science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile